NCT00319839 Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab Status TERMINATED Phase PHASE2
NCT00318890 Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT00318604 Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker Status UNKNOWN Phase N/A
NCT00316823 Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules Status COMPLETED Phase NA
NCT00313027 Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation Status COMPLETED Phase NA
NCT00310115 Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy Status COMPLETED Phase N/A
NCT00304278 Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA) Status COMPLETED Phase PHASE2
NCT00301028 Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00293579 Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00293462 GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00291707 Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00291434 Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer Status COMPLETED Phase N/A
NCT00281866 Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00281840 Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00280891 Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer Status COMPLETED Phase N/A
NCT00276523 PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00272181 Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00270790 EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) Status COMPLETED Phase PHASE2
NCT00268372 S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx Status TERMINATED Phase PHASE3